Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'

• Status: Unknown status
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators aim is to investigate whether adjuvant Pentoxifylline , IgM enriched IVIG or Pentoxifylline plus IgM-enriched IVIG reduced mortality from Neonatal sepsis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital
• Treatments: Antibodies; gamma-Globulins; Immunoglobulins; Immunoglobulins, Intravenous; Pentoxifylline; Rho(D) Immune Globulin

Criteria

Inclusion Criteria::

• All infants thought/diagnosed to have late or early onset sepsis.

Exclusion Criteria:

• Pentoxifylline or Pentaglobin has already been given

• Pentoxifylline or Pentaglobin is thought to be needed or contra-indicated

• Major congenital anomaly

• Intraventricular hemorrhage (Grade 3 veya 4)

• Congenital infections

• Inborn errors of metabolism